LCN2 and metabolic dysfunction-associated steatohepatitis: CK18 and LCN2 reflect hepatocellular apoptosis and tissue damage, while OPN and PTX3 are involved in inflammation-mediated fibrogenesis, aiding in the identification of NASH and advanced high-risk patients.